These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2198142)

  • 41. [Observations on the anti-arrhythmic effects of propafenone].
    Ku FS
    Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):658-61. PubMed ID: 7166067
    [No Abstract]   [Full Text] [Related]  

  • 42. Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
    Libersa C; Caron J; Pladys A; Beuscart R; Kacet S; Wajman A; Connell C; Dupuis B; Lekieffre J
    Clin Cardiol; 1987 Jul; 10(7):405-10. PubMed ID: 2440632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrophysiological mechanism for the antiarrhythmic action of propafenone: a comparison with mexiletine.
    Amerini S; Bernabei R; Carbonin P; Cerbai E; Mugelli A; Pahor M
    Br J Pharmacol; 1988 Dec; 95(4):1039-46. PubMed ID: 3219479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Propafenone in the treatment of cardiac arrhythmias].
    Podzolkov VI; Tarzimanova AI
    Kardiologiia; 2012; 52(5):70-3. PubMed ID: 22839589
    [No Abstract]   [Full Text] [Related]  

  • 46. [The effect of the new antiarrhythmic drug mexiletine on sinus node and intracardiac conduction in man (author's transl)].
    Seipel L; Breithardt G; Schoerner U
    Z Kardiol; 1978 Nov; 67(11):766-70. PubMed ID: 726555
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of propafenone and disopyramide in the treatment of ventricular premature complexes: a randomized double blind crossover placebo controlled trial.
    Rabkin SW; Boroomand-Rashti K; McKinnon J; Rotem CE
    Can J Cardiol; 1987 Apr; 3(3):105-10. PubMed ID: 3297265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy].
    Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F
    G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Propafenone in the treatment of high-risk ventricular arrhythmias].
    Pepi R; Rotatori D; Mori A; Nascimbeni F
    Clin Ter; 1986 Aug; 118(4):247-52. PubMed ID: 3757464
    [No Abstract]   [Full Text] [Related]  

  • 50. Propafenone for cardiac arrhythmias.
    Birgersdotter-Green U
    Am J Med Sci; 1992 Feb; 303(2):123-8. PubMed ID: 1539611
    [No Abstract]   [Full Text] [Related]  

  • 51. Specific drugs for specific ventricular arrhythmias: an evaluation of current therapy and the role of propafenone.
    Murtazam A; Campbell RW
    Eur Heart J; 1989 Sep; 10 Suppl E():41-7. PubMed ID: 2680501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tiracizine in the treatment of ventricular arrhythmia (preliminary study)].
    Stejfa M; Zeman K; Groch L; Bytesník J; Krausová R
    Vnitr Lek; 1993 Jun; 39(6):549-53. PubMed ID: 8212608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experience with propafenone for the treatment of cardiac arrhythmias in children.
    Celiker A; Ozer S; Ozme S; Ozkutlu S; Kahramanyol O
    Turk J Pediatr; 1990; 32(2):85-92. PubMed ID: 2091375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propafenone, a review of its profile.
    Schlepper M
    Eur Heart J; 1987 Mar; 8 Suppl A():27-32. PubMed ID: 3556176
    [No Abstract]   [Full Text] [Related]  

  • 55. [Efficacy and tolerance of propafenone in the treatment of cardiac rhythm disorders. Evaluation of a multicenter open trial on 3,687 patients].
    Clémenty J; Coste P; Metzinger M
    Ann Cardiol Angeiol (Paris); 1987 Apr; 36(4):207-12. PubMed ID: 3296928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urticaria-angioedema reaction caused by propafenone.
    Incorvaia C; Pravettoni C; Riario-Sforza GG
    Allergy; 2006 Feb; 61(2):269. PubMed ID: 16409210
    [No Abstract]   [Full Text] [Related]  

  • 57. Propafenone.
    Funck-Brentano C; Kroemer HK; Lee JT; Roden DM
    N Engl J Med; 1990 Feb; 322(8):518-25. PubMed ID: 2405273
    [No Abstract]   [Full Text] [Related]  

  • 58. Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient.
    Brunozzi LT; Meniconi L; Chiocchi P; Liberati R; Zuanetti G; Latini R
    Br J Clin Pharmacol; 1988 Oct; 26(4):489-90. PubMed ID: 3191001
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.
    Touboul P; Moleur P; Mathieu MP; Vrancea F; Ferry S; Kirkorian G; Atallah G; Marchand A; Stahl C; Zoheir F
    Eur Heart J; 1988 Nov; 9(11):1188-93. PubMed ID: 3234410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The electrophysiologic effects of propafenone hydrochloride in the neonatal canine.
    Villafane J; Gelband H; Xu H; McCormack J; Stolfi A; Pickoff AS
    Pediatr Res; 1987 Jul; 22(1):50-4. PubMed ID: 3627871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.